Pennsylvania Cancer Registry
The Health Insurance Portability and Accountability Act (HIPAA) allows for the reporting of identifiable cancer data to public health entities. Because the PCR falls under the definition of a public health entity, HIPAA allows facilities to report data to the PCR in compliance with Pennsylvania state laws and regulations. Written informed consent from each cancer patient reported to public health entities is not required under HIPAA
Recent shifts in cancer diagnosis and treatment away from hospitals towards ambulatory healthcare settings are increasing the importance of ambulatory (non-hospital) healthcare providers’ data for cancer surveillance. Reporting to the PCR by physicians addresses current underreporting of certain types of treatment (e.g., radiation therapy), and cancers that are primarily seen in an outpatient setting (e.g., hematopoietic, early stage melanoma, prostate, colorectal, and breast cancers).
Options for physician reporting include:
Reporting through electronic health record (EHR) technology
Reporting through certified EHR technology
is required for Meaningful Use (MU) cancer reporting. Physicians interested in reporting through EHR technology but not pursuing MU objectives should contact the PCR by e-mail
Other reporting options are currently under development. Physicians interested in discussing other reporting options should contact the PCR by e-mail